With a robust background in financial analysis and strategic management, Brian Szymczak has made significant contributions within the capital markets. His expertise spans both private equity transactions and operational improvements, reflecting a comprehensive understanding of value creation across various industries. In his role as an operating executive, he emphasizes leveraging analytical insights to drive decision-making processes that enhance organizational performance. This blend of hands-on leadership and investment acumen positions him as a notable figure in today’s dynamic financial landscape.
With a robust background in financial analysis and strategic management, Brian Szymczak has made significant contributions within the capital markets. His expertise spans both private equity transactions and operational improvements, reflecting a comprehensive understanding of value creation across various industries. In his role as an operating executive, he emphasizes leveraging analytical insights to drive decision-making processes that enhance organizational performance. This blend of hands-on leadership and investment acumen positions him as a notable figure in today’s dynamic financial landscape.
Risk assessment is integral to investment choices, particularly in volatile markets. Brian Szymczak draws on his extensive experience to identify mispriced assets, utilizing a contrarian approach that seeks value where others may overlook potential. His strategic insights enable targeted investments that balance growth with prudent risk management. The focus lies on uncovering underappreciated opportunities, emphasizing rigorous analysis and proactive adjustments based on evolving market dynamics. This blend of financial savvy and leadership allows him to navigate complexities while remaining committed to driving sustainable growth through calculated investments.
Risk assessment is integral to investment choices, particularly in volatile markets. Brian Szymczak draws on his extensive experience to identify mispriced assets, utilizing a contrarian approach that seeks value where others may overlook potential. His strategic insights enable targeted investments that balance growth with prudent risk management. The focus lies on uncovering underappreciated opportunities, emphasizing rigorous analysis and proactive adjustments based on evolving market dynamics. This blend of financial savvy and leadership allows him to navigate complexities while remaining committed to driving sustainable growth through calculated investments.
| Trades 260 | Longs Won 162/260 62% | Profit Factor 4.5 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $136,644.5 |
| Average Win $68,542.96 | Best Trade (Jun 30) $876,351.85 | Sharpe Ratio -205.51 |
| Average Loss -$25,174.97 | Worst Trade (Oct 14) -$763,103.41 | Z-Score 0.71 (52.32%) |
| Commissions $0 | Avg. Trade Length 7m 4w | Expectancy $37,914.9 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 3,546 | 3,191 | 2,837 | 2,482 | 2,128 | 1,773 | 1,418 | 1,064 | 709 | 355 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 3,768 | $979,231.54 | $1.3M | - | $316,847.42 | 32.36% | +0.294% |
ABBV AbbVie Inc. | 5,767 | $1.26M | $1.67M | - | $403,424.04 | 31.96% | +1.877% |
ABT Abbott Laboratories | 6,220 | $638,607.62 | $652,540.2 | - | $13,932.58 | 2.18% | +1.884% |
BILZ PIMCO Ultra Short Government Active Exchange-Traded Fund | 51,511 | $5.2M | $5.19M | - | -$14,219.91 | -0.27% | -0.005% |
CORO Ishares International Country Rotational Active ETF | 6,818 | $219,219.08 | $242,243.54 | - | $23,024.46 | 10.5% | -0.169% |
CSCO Cisco Systems, Inc. | 1,834 | $141,272.99 | $199,447.5 | - | $58,174.51 | 41.18% | -4.303% |
DECT AllianzIM U.S. Large Cap Buffer10 December ETF | 99,732 | $3.18M | $4.06M | - | $874,535.11 | 27.47% | 0.0 |
DECU AllianzIM U.S. Large Cap Buffer10 Dec ETF | 7,552 | $202,997.77 | $224,143.36 | - | $21,145.59 | 10.42% | -1.198% |
DECW AllianzIM U.S. Large Cap Buffer20 Dec ETF | 129,916 | $3.99M | $4.77M | - | $780,513.11 | 19.55% | +0.174% |
DYNF iShares U.S. Equity Factor Rotation Active ETF | 3,587 | $191,934.77 | $248,399.75 | - | $56,464.98 | 29.42% | -0.274% |
FEBT AllianzIM U.S. Large Cap Buffer10 Feb ETF | 62,476 | $2.57M | $2.65M | - | $84,036.86 | 3.27% | +0.153% |
FEBW AllianzIM U.S. Large Cap Buffer20 February ETF | 142,672 | $5.07M | $5.21M | - | $139,833.44 | 2.76% | +0.177% |
GLD SPDR Gold Shares | 1,285 | $323,973.78 | $489,186.65 | - | $165,212.87 | 51% | +1.25% |
GMAY FT Vest U.S. Equity Moderate GMAY Fund | 118,782 | $5.11M | $5.25M | - | $136,005.68 | 2.66% | +0.17% |
IVW ISHARES S&P 500 GROWTH ETF (3IS8) | 1,458 | $148,030.73 | $205,825.86 | - | $57,795.13 | 39.04% | -0.458% |
JANW AllianzIM U.S. Large Cap Buffer20 January ETF | 152,142 | $5.12M | $6.05M | - | $925,450.8 | 18.06% | +0.113% |
JPST JPMorgan Ultra-Short Income ETF | 8,621 | $434,239.58 | $433,722.51 | - | -$517.07 | -0.12% | +0.02% |
JUNT AllianzIM U.S. Large Cap Buffer10 Jun ETF | 82,030 | $3.1M | $3.18M | - | $83,260.15 | 2.69% | +0.129% |
JUNW AllianzIM U.S. Large Cap Buffer20 Jun ETF | 175,439 | $6.03M | $6.16M | - | $128,949.87 | 2.14% | +0.071% |
MAYT AllianzIM U.S. Large Cap Buffer10 May ETF | 128,454 | $5.01M | $5.16M | - | $150,612.17 | 3.01% | +0.1% |